Investment Dossier
ResearchCapabilitiesMarket coverageSign inCreate an account

PUBLIC EQUITY RESEARCH

Arm Holdings plc - American Depositary Shares

United States · ARM

Latest published edition
2026.07.19.2
Report generated
July 19, 2026

Keep reading in My Dossiers

DOSSIER PREVIEW

Read the opening section of this investment dossier

Review selected opening pages before adding this dossier to your library.

Reviewed research summaryPublished research overviewApplied Materials is a high-quality, cross-process semiconductor materials engineering platform whose stock at $529.66 already prices in substantial FY2027 growth and a structurally elevated valuation. The report's 12-month probability-weighted value is $452, implying a -14.7% expected return, leading to a 'wait for a better price' recommendation with medium confidence. AMAT's competitive moat stems from cross-step coordination in integrated materials solutions spanning deposition, etch, CMP, and metrology, positioned to benefit from GAA transistor transitions, backside power delivery, DRAM/HBM complexity, and advanced packaging growth.

Start with the core view, then expand the complete published overview whenever you need more detail.

Applied Materials is a high-quality, cross-process semiconductor materials engineering platform whose stock at $529.66 already prices in substantial FY2027 growth and a structurally elevated valuation. The report's 12-month probability-weighted value is $452, implying a -14.7% expected return, leading to a 'wait for a better price' recommendation with medium confidence. AMAT's competitive moat stems from cross-step coordination in integrated materials solutions spanning deposition, etch, CMP, and metrology, positioned to benefit from GAA transistor transitions, backside power delivery, DRAM/HBM complexity, and advanced packaging growth.

Read the full overview

Financially, FY2025 free cash flow declined approximately 24% year over year to $5.7B as Capex surged to $2.26B, and the LTM FCF yield is only about 1.27%. The valuation demands near-flawless execution: the current price equals 35.8x FY2027E Non-GAAP EPS and the market enterprise value is roughly 1.75x the Base DCF. Material risks include China export controls with BIS compliance tail risks, rising domestic substitution from NAURA and AMEC, customer concentration, and the unproven cash-flow conversion of EPIC and capacity expansion investments.

Key catalysts include Q3/Q4 guidance delivery, GAA and HBM tool acceptance with repeat orders, and a cash-flow recovery validated by inventory and receivables growing more slowly than revenue.

PUBLICATION RECORDResearch context

Use the edition date, review status, coverage and available languages to understand the context of this research.

Latest published edition
2026.07.19.2
Report generated
July 19, 2026
Publication status
Reviewed for publication
Research reviewed
July 20, 2026
Public page updated
July 21, 2026
Report directory
14 published report modules
Available languages
10 published languages
Report directoryCore modules included in this edition
  1. 01Research Framework and Key Snapshot
  2. 02Investment Conclusion and Bull-Bear Debate
  3. 03What the Current Price Implies
  4. 04Business Model and Segment Economics
  5. 05WFE Cycle and Customer Capital Expenditures
  6. 06DRAM, HBM, and Advanced Packaging
  7. 07AGS: Quality and Limits of Recurring Revenue
  8. 08Competitive Landscape and Share Evidence
  9. 09China, Export Controls, and Domestic Substitution
  10. 10EPIC, Capacity Expansion, R&D, and Capital Allocation
  11. 11Financial Quality and FY2026E–FY2029E Model
  12. 12Valuation, Sensitivity, and Four Scenarios
  13. 13Catalysts, Dashboard, and Trading Discipline
  14. 14Numbered Sources